Diatherix Laboratories

An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent.

The companies will use their respective technologies to develop multiplex molecular diagnostic panels for laboratory testing.

Under the terms of the deal, IQuity's autoimmune disease diagnostics will be made available through Diatherix's CLIA-certified clinical laboratory.

The provider of multiplex diagnostics services and solutions will work with VUMC to develop infectious disease assays with a particular focus on pediatric patients.

Diatherix and Color Genomics now carry both CLIA certification and CAP accreditation.

The acquisition expands the firm's specialty clinical diagnostics footprint.

Enrichment prior to amplification better enables studies of non-coding regions and epigenetic analyses, according to Ubiquity's founder.

The contract is to further the company's work to develop methodologies aimed at Francisella tularensis, Escherichia coli, and Babesia microti.

Diatherix Laboratories, an independent CLIA-certified clinical laboratory providing multiplex molecular diagnostic services, said this week that it recently acquired from Qiagen the patent to target-enriched multiplexing, or TEM, PCR — a patent that Diatherix previously licensed

NEW YORK (GenomeWeb News) – Diatherix Laboratories today announced it has acquired from Qiagen a patent covering technology for rapidly identifying multiple infectious disease organisms.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.